Abstract
In utero exposure to antiepileptic drugs carries teratogenic risks, but little is known about the potential effects of such agents on neurocognitive development. The results from a large prospective study that set out to address this issue add to the mounting evidence against the use of valproate in women with epilepsy during childbearing years.
Original language | English |
---|---|
Pages (from-to) | 414-415 |
Number of pages | 2 |
Journal | Nature Reviews Neurology |
Volume | 5 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2009 |